Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: a <i>post hoc</i> analysis of the phase 2b/3 SELECTION study
Symptomatic response to FIL200 occurred more rapidly in the less severe disease groups than in the more severe disease groups; however, regardless of disease severity, both groups benefited from continued FIL200 treatment.
Authors
- Yoshie Takatori-Shirakami (ORCID: https://orcid.org/0009-0005-2785-2726)
- Toshifumi Hibi∥ (ORCID: https://orcid.org/0000-0002-6256-1204)
- Marc Ferrante (ORCID: https://orcid.org/0000-0003-1492-0716)
- Christine Rudolph (ORCID: https://orcid.org/0000-0002-7678-6519)
- Silvio Danese (ORCID: https://orcid.org/0000-0001-7341-1351)
- Masayuki Saruta (ORCID: https://orcid.org/0000-0001-8172-3240)
- Toshihiko Kaise (ORCID: https://orcid.org/0000-0001-6059-7900)
Institutions
- Jikei University School of Medicine (JP)
- Vita-Salute San Raffaele University (IT)
- Alfasigma (Italy) (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Kitasato Institute Hospital (JP)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- Kitasato University (JP)
- KU Leuven (BE)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-06-30
- DOI
- https://doi.org/10.5217/ir.2024.00169
- Primary Topic
- Microscopic Colitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00